Yettwaleqqem
WHO updated recommendations on HIV clinical management: recommendations for a public health approach
World Health Organization
Tuḍḍiwin n tɣawsiwin 2025TAFFA N TMUSNIWIN TUSNANIN
Ilugan n usḍibbi
Af-d ilugan unṣiben, arraten n umtawa d yileqman i d-ssufɣen yimusnawen d tedbirtin n ṣṣeḥḥa.
Iɣbula unṣiben, yettwamanenTuddsiwin tusnawin d tedbirtin n ṣṣeḥḥa
Isallen yettwaleqqmenAsenqed ussnan ameɣlal
Anekcum s war azal i yimseɣtayenI ɣur n temɣiwent n yimdanen n tẓṛi
Tisuffaɣ d ileqman ixataren
Wali isuffeɣen ineggura
Yettwaleqqem
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
European Society of Cardiology
Tasleḍt n wul 2025
Asuffeɣ unṣib
Evidence-informed diagnosis of cerebral palsy in community settings
Canadian Paediatric Society
Taseḍṛit n warrac 2026Akk yilugan (126 igmuḍ)
Imsizzel
Archived 45: Summary of NACI statement of October 7, 2022: Updated guidance on COVID-19 vaccine booster doses in Canada
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 45: Summary of NACI statement of October 7, 2022: Updated guidance on COVID-19 vaccine booster dos...
Archived 45: Updated guidance on COVID-19 vaccine booster doses in Canada [2022-10-07]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 45: Updated guidance on COVID-19 vaccine booster doses in Canada [2022-10-07]”. Updated guidance o...
Archived 46: Summary of NACI statement of October 21, 2022: Recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years of age
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 46: Summary of NACI statement of October 21, 2022: Recommendations on the use of Pfizer-BioNTech C...
Archived 46: Recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years of age [2022-10-21]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 46: Recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6...
Archived 47: Summary of National Advisory Committee on Immunization (NACI) updates of November 3, 2022: Recommendations on the use of Moderna Spikevax BA.4/5 bivalent mRNA (50 mcg) COVID-19 booster vaccine in adults
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 47: Summary of National Advisory Committee on Immunization (NACI) updates of November 3, 2022: Rec...
Archived 48: Summary of NACI statement of December 9, 2022: Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 48: Summary of NACI statement of December 9, 2022: Updated recommendations on the use of COVID-19...
Archived 48: Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration [December 9, 2022]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 48: Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years...
Archive 30: Summary of updates in the Canadian Immunization Guide of June 3, 2022: Updated guidance on COVID-19 vaccines in Canada [2022-06-03]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archive 30: Summary of updates in the Canadian Immunization Guide of June 3, 2022: Updated guidance on COVI...
Archive 38: Summary of updates in the Canadian Immunization Guide of June 21 2022: Updated guidance on COVID-19 vaccines in Canada [2022-06-21]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archive 38: Summary of updates in the Canadian Immunization Guide of June 21 2022: Updated guidance on COVI...
Archive 40: Summary of updates in the Canadian Immunization Guide of August 29, 2022: Updated guidance on COVID-19 vaccines in Canada [2022-08-29]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archive 40: Summary of updates in the Canadian Immunization Guide of August 29, 2022: Updated guidance on C...